Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hmga1
|
ENSMUSG00000046711.9 | high mobility group AT-hook 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr17_27559013_27559762 | Hmga1 | 2692 | 0.110246 | -0.58 | 1.4e-06 | Click! |
chr17_27560077_27560493 | Hmga1 | 3590 | 0.094391 | -0.54 | 9.5e-06 | Click! |
chr17_27558079_27558612 | Hmga1 | 1650 | 0.160273 | -0.53 | 1.6e-05 | Click! |
chr17_27554987_27555138 | Hmga1 | 1435 | 0.170835 | -0.49 | 8.3e-05 | Click! |
chr17_27554827_27554978 | Hmga1 | 1595 | 0.154010 | -0.46 | 2.1e-04 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr12_71048832_71049275 | 11.62 |
Arid4a |
AT rich interactive domain 4A (RBP1-like) |
712 |
0.65 |
chr16_77594640_77595970 | 10.99 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
403 |
0.71 |
chr18_23036665_23037864 | 10.89 |
Nol4 |
nucleolar protein 4 |
1392 |
0.59 |
chr16_77503379_77503945 | 9.17 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
3278 |
0.16 |
chr6_136170568_136170996 | 8.89 |
Grin2b |
glutamate receptor, ionotropic, NMDA2B (epsilon 2) |
1107 |
0.5 |
chr4_97868552_97869863 | 8.64 |
Nfia |
nuclear factor I/A |
10912 |
0.28 |
chr3_56179928_56180616 | 8.24 |
Nbea |
neurobeachin |
3429 |
0.25 |
chr1_3668321_3668726 | 8.24 |
Xkr4 |
X-linked Kx blood group related 4 |
2975 |
0.22 |
chr15_39392966_39393260 | 7.98 |
Rims2 |
regulating synaptic membrane exocytosis 2 |
1313 |
0.57 |
chr8_34890130_34891317 | 7.14 |
Tnks |
tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase |
572 |
0.8 |
chr4_25797578_25797990 | 6.92 |
Fut9 |
fucosyltransferase 9 |
2071 |
0.32 |
chr11_94045498_94046076 | 6.78 |
Spag9 |
sperm associated antigen 9 |
1422 |
0.4 |
chr5_43236032_43236320 | 6.50 |
Gm7854 |
predicted gene 7854 |
821 |
0.45 |
chr1_169934022_169934472 | 6.49 |
Gm15852 |
predicted gene 15852 |
1 |
0.97 |
chrX_23283125_23283785 | 6.42 |
Klhl13 |
kelch-like 13 |
1374 |
0.57 |
chr1_78537079_78538149 | 6.39 |
Mogat1 |
monoacylglycerol O-acyltransferase 1 |
14 |
0.97 |
chr15_85679298_85680211 | 6.36 |
Lncppara |
long noncoding RNA near Ppara |
24019 |
0.12 |
chr4_102256022_102256825 | 6.31 |
Pde4b |
phosphodiesterase 4B, cAMP specific |
1193 |
0.63 |
chrX_9201266_9201702 | 6.23 |
Lancl3 |
LanC lantibiotic synthetase component C-like 3 (bacterial) |
1582 |
0.33 |
chr5_43236846_43237650 | 6.21 |
Cpeb2 |
cytoplasmic polyadenylation element binding protein 2 |
67 |
0.96 |
chr6_55680133_55680881 | 6.09 |
Neurod6 |
neurogenic differentiation 6 |
756 |
0.69 |
chr7_91544069_91544395 | 5.88 |
Dlg2 |
discs large MAGUK scaffold protein 2 |
1143 |
0.45 |
chr4_82497680_82498758 | 5.84 |
Nfib |
nuclear factor I/B |
1097 |
0.54 |
chr1_66323360_66324079 | 5.84 |
Map2 |
microtubule-associated protein 2 |
1617 |
0.37 |
chr3_146769678_146770812 | 5.75 |
Prkacb |
protein kinase, cAMP dependent, catalytic, beta |
16 |
0.98 |
chr5_77113895_77114483 | 5.70 |
Hopx |
HOP homeobox |
932 |
0.47 |
chr6_136169672_136170219 | 5.70 |
Grin2b |
glutamate receptor, ionotropic, NMDA2B (epsilon 2) |
1944 |
0.34 |
chr13_81570195_81570888 | 5.67 |
Adgrv1 |
adhesion G protein-coupled receptor V1 |
99 |
0.98 |
chrX_82949777_82950054 | 5.60 |
Dmd |
dystrophin, muscular dystrophy |
1012 |
0.71 |
chr12_71049290_71050137 | 5.59 |
Arid4a |
AT rich interactive domain 4A (RBP1-like) |
1372 |
0.4 |
chr4_102254418_102255744 | 5.55 |
Pde4b |
phosphodiesterase 4B, cAMP specific |
78 |
0.99 |
chr11_94044930_94045437 | 5.52 |
Spag9 |
sperm associated antigen 9 |
818 |
0.6 |
chr15_40658220_40658522 | 5.52 |
Zfpm2 |
zinc finger protein, multitype 2 |
3020 |
0.37 |
chr14_75963713_75963971 | 5.52 |
Gm25517 |
predicted gene, 25517 |
8777 |
0.18 |
chr4_76447798_76447949 | 5.51 |
Ptprd |
protein tyrosine phosphatase, receptor type, D |
2107 |
0.33 |
chr14_39468995_39469474 | 5.50 |
Nrg3 |
neuregulin 3 |
3432 |
0.39 |
chr5_107498136_107498752 | 5.43 |
Btbd8 |
BTB (POZ) domain containing 8 |
665 |
0.57 |
chr5_150261018_150262108 | 5.43 |
Fry |
FRY microtubule binding protein |
1796 |
0.34 |
chr12_31711839_31712627 | 5.42 |
Gpr22 |
G protein-coupled receptor 22 |
1693 |
0.32 |
chr8_94266327_94267391 | 5.40 |
Nup93 |
nucleoporin 93 |
12 |
0.96 |
chr7_87584791_87585125 | 5.38 |
Grm5 |
glutamate receptor, metabotropic 5 |
560 |
0.85 |
chr4_36949065_36949216 | 5.37 |
Lingo2 |
leucine rich repeat and Ig domain containing 2 |
1327 |
0.49 |
chr9_112232861_112233588 | 5.36 |
Arpp21 |
cyclic AMP-regulated phosphoprotein, 21 |
402 |
0.75 |
chr5_7342956_7343453 | 5.35 |
Zfp804b |
zinc finger protein 804B |
1552 |
0.41 |
chr10_14017752_14018957 | 5.34 |
Hivep2 |
human immunodeficiency virus type I enhancer binding protein 2 |
51330 |
0.13 |
chr3_16818309_16818538 | 5.26 |
Gm26485 |
predicted gene, 26485 |
4889 |
0.36 |
chr3_18057185_18057526 | 5.24 |
Bhlhe22 |
basic helix-loop-helix family, member e22 |
3181 |
0.25 |
chr3_26151491_26152156 | 5.21 |
Nlgn1 |
neuroligin 1 |
1484 |
0.58 |
chr11_43834010_43835381 | 5.17 |
Adra1b |
adrenergic receptor, alpha 1b |
1637 |
0.47 |
chr10_101681584_101682324 | 5.13 |
Mgat4c |
MGAT4 family, member C |
208 |
0.96 |
chr18_31446492_31447667 | 5.11 |
Syt4 |
synaptotagmin IV |
327 |
0.87 |
chr3_123688820_123689480 | 5.07 |
Ndst3 |
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 3 |
1130 |
0.37 |
chr12_53124336_53124694 | 4.95 |
n-R5s58 |
nuclear encoded rRNA 5S 58 |
77689 |
0.11 |
chr17_91090702_91091377 | 4.95 |
Nrxn1 |
neurexin I |
1694 |
0.28 |
chr12_61525659_61526870 | 4.95 |
Lrfn5 |
leucine rich repeat and fibronectin type III domain containing 5 |
2316 |
0.3 |
chr11_32001099_32002296 | 4.95 |
Nsg2 |
neuron specific gene family member 2 |
1195 |
0.52 |
chr1_160349793_160349968 | 4.94 |
Rabgap1l |
RAB GTPase activating protein 1-like |
1691 |
0.33 |
chr5_103209022_103210413 | 4.89 |
Mapk10 |
mitogen-activated protein kinase 10 |
705 |
0.75 |
chr14_60380755_60381381 | 4.88 |
Amer2 |
APC membrane recruitment 2 |
2782 |
0.3 |
chr17_57771236_57771741 | 4.87 |
Cntnap5c |
contactin associated protein-like 5C |
1918 |
0.27 |
chr4_116405137_116405599 | 4.87 |
Mast2 |
microtubule associated serine/threonine kinase 2 |
618 |
0.74 |
chr12_29529828_29531185 | 4.87 |
Gm20208 |
predicted gene, 20208 |
609 |
0.74 |
chr13_46421073_46421328 | 4.84 |
Rbm24 |
RNA binding motif protein 24 |
622 |
0.78 |
chr16_77418973_77419718 | 4.80 |
9430053O09Rik |
RIKEN cDNA 9430053O09 gene |
2475 |
0.17 |
chr2_84647866_84648354 | 4.75 |
Ctnnd1 |
catenin (cadherin associated protein), delta 1 |
427 |
0.69 |
chr6_134924300_134924738 | 4.75 |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
4006 |
0.13 |
chr2_38196447_38197128 | 4.74 |
Gm44455 |
predicted gene, 44455 |
28335 |
0.16 |
chr1_168424564_168424950 | 4.74 |
Pbx1 |
pre B cell leukemia homeobox 1 |
6747 |
0.26 |
chr16_77645925_77646470 | 4.73 |
Mir125b-2 |
microRNA 125b-2 |
76 |
0.58 |
chr1_120117736_120117919 | 4.72 |
Dbi |
diazepam binding inhibitor |
2311 |
0.27 |
chr5_65133357_65133508 | 4.72 |
Klhl5 |
kelch-like 5 |
1761 |
0.29 |
chr9_4791870_4792180 | 4.67 |
Gria4 |
glutamate receptor, ionotropic, AMPA4 (alpha 4) |
3494 |
0.38 |
chr1_143642293_143642622 | 4.66 |
Cdc73 |
cell division cycle 73, Paf1/RNA polymerase II complex component |
68 |
0.97 |
chr2_65565600_65566271 | 4.64 |
Scn3a |
sodium channel, voltage-gated, type III, alpha |
1557 |
0.45 |
chr1_66322405_66322814 | 4.64 |
Map2 |
microtubule-associated protein 2 |
507 |
0.79 |
chr5_23615585_23615736 | 4.62 |
Srpk2 |
serine/arginine-rich protein specific kinase 2 |
874 |
0.59 |
chr1_66322822_66322976 | 4.61 |
Map2 |
microtubule-associated protein 2 |
797 |
0.63 |
chr14_96515489_96515743 | 4.59 |
Klhl1 |
kelch-like 1 |
3486 |
0.32 |
chr11_64759349_64759634 | 4.58 |
Gm12291 |
predicted gene 12291 |
536 |
0.86 |
chr11_108607202_108607707 | 4.58 |
Cep112 |
centrosomal protein 112 |
2227 |
0.37 |
chr12_31712647_31712798 | 4.56 |
Gpr22 |
G protein-coupled receptor 22 |
1204 |
0.43 |
chr15_23037371_23038142 | 4.56 |
Cdh18 |
cadherin 18 |
1293 |
0.6 |
chr17_91086370_91086959 | 4.55 |
Gm47307 |
predicted gene, 47307 |
1742 |
0.26 |
chr9_112231189_112232055 | 4.55 |
Arpp21 |
cyclic AMP-regulated phosphoprotein, 21 |
280 |
0.9 |
chr8_94269367_94270471 | 4.54 |
Nup93 |
nucleoporin 93 |
1313 |
0.31 |
chr10_53337944_53338408 | 4.54 |
Pln |
phospholamban |
471 |
0.73 |
chr18_16805598_16806159 | 4.54 |
Cdh2 |
cadherin 2 |
2584 |
0.29 |
chr1_66176824_66177184 | 4.53 |
Map2 |
microtubule-associated protein 2 |
1454 |
0.52 |
chr12_61527334_61527568 | 4.52 |
Lrfn5 |
leucine rich repeat and fibronectin type III domain containing 5 |
3503 |
0.24 |
chr6_136171003_136171483 | 4.51 |
Grin2b |
glutamate receptor, ionotropic, NMDA2B (epsilon 2) |
646 |
0.69 |
chr4_82499658_82501360 | 4.48 |
Nfib |
nuclear factor I/B |
1193 |
0.5 |
chr15_18820164_18820708 | 4.47 |
Cdh10 |
cadherin 10 |
107 |
0.96 |
chr4_82502069_82502416 | 4.47 |
Nfib |
nuclear factor I/B |
2926 |
0.27 |
chr15_85674019_85674170 | 4.44 |
Lncppara |
long noncoding RNA near Ppara |
20478 |
0.13 |
chr13_8205020_8205313 | 4.43 |
Adarb2 |
adenosine deaminase, RNA-specific, B2 |
2244 |
0.28 |
chrX_23294952_23295287 | 4.42 |
Klhl13 |
kelch-like 13 |
1039 |
0.66 |
chr4_116405618_116406369 | 4.41 |
Mast2 |
microtubule associated serine/threonine kinase 2 |
7 |
0.98 |
chr17_10314038_10315183 | 4.39 |
Qk |
quaking |
4751 |
0.26 |
chr1_140661037_140661562 | 4.36 |
4930590L20Rik |
RIKEN cDNA 4930590L20 gene |
4895 |
0.34 |
chr7_60623066_60623220 | 4.36 |
Gm3198 |
predicted gene 3198 |
20748 |
0.24 |
chr13_84063384_84064052 | 4.34 |
Gm17750 |
predicted gene, 17750 |
1054 |
0.58 |
chr13_28419787_28420291 | 4.34 |
Gm40841 |
predicted gene, 40841 |
27 |
0.98 |
chr9_113792658_113793898 | 4.32 |
Clasp2 |
CLIP associating protein 2 |
48 |
0.98 |
chr11_94046147_94046506 | 4.30 |
Spag9 |
sperm associated antigen 9 |
1961 |
0.31 |
chr2_19660039_19660459 | 4.29 |
Otud1 |
OTU domain containing 1 |
2497 |
0.19 |
chr16_77502982_77503216 | 4.27 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
2715 |
0.18 |
chr10_33083961_33084356 | 4.26 |
Trdn |
triadin |
597 |
0.81 |
chr1_66324716_66324867 | 4.25 |
Map2 |
microtubule-associated protein 2 |
2689 |
0.25 |
chr12_46812593_46812909 | 4.25 |
Gm48542 |
predicted gene, 48542 |
1243 |
0.48 |
chr19_15997676_15997827 | 4.23 |
C130060C02Rik |
RIKEN cDNA C130060C02 gene |
12673 |
0.16 |
chr19_59541762_59542770 | 4.22 |
Gm18161 |
predicted gene, 18161 |
1815 |
0.38 |
chr10_12613847_12614341 | 4.18 |
Utrn |
utrophin |
737 |
0.78 |
chr7_73555476_73555660 | 4.18 |
1810026B05Rik |
RIKEN cDNA 1810026B05 gene |
352 |
0.79 |
chr16_43505394_43505961 | 4.15 |
Zbtb20 |
zinc finger and BTB domain containing 20 |
1980 |
0.41 |
chr4_109343653_109343847 | 4.14 |
Eps15 |
epidermal growth factor receptor pathway substrate 15 |
497 |
0.8 |
chr6_13837266_13838183 | 4.13 |
Gpr85 |
G protein-coupled receptor 85 |
483 |
0.82 |
chr18_43389837_43390467 | 4.10 |
Dpysl3 |
dihydropyrimidinase-like 3 |
3225 |
0.29 |
chr1_112456627_112457016 | 4.10 |
Gm22331 |
predicted gene, 22331 |
11090 |
0.28 |
chr3_8509825_8511666 | 4.09 |
Stmn2 |
stathmin-like 2 |
1159 |
0.54 |
chr2_178329116_178330024 | 4.09 |
Phactr3 |
phosphatase and actin regulator 3 |
1778 |
0.41 |
chr3_28264634_28265464 | 4.08 |
Tnik |
TRAF2 and NCK interacting kinase |
1406 |
0.45 |
chr12_52699339_52699808 | 4.07 |
Akap6 |
A kinase (PRKA) anchor protein 6 |
190 |
0.95 |
chr5_92386923_92387342 | 4.05 |
Art3 |
ADP-ribosyltransferase 3 |
245 |
0.87 |
chr18_25750468_25751272 | 4.04 |
Celf4 |
CUGBP, Elav-like family member 4 |
1822 |
0.41 |
chrX_66657509_66657976 | 4.03 |
Slitrk2 |
SLIT and NTRK-like family, member 2 |
4735 |
0.2 |
chr2_107292125_107293014 | 4.02 |
Kcna4 |
potassium voltage-gated channel, shaker-related subfamily, member 4 |
1174 |
0.64 |
chr16_13357876_13359918 | 4.00 |
Mrtfb |
myocardin related transcription factor B |
476 |
0.83 |
chr16_50689310_50689541 | 3.95 |
Gm9575 |
predicted gene 9575 |
23079 |
0.17 |
chr7_62366195_62366527 | 3.94 |
Magel2 |
melanoma antigen, family L, 2 |
10649 |
0.18 |
chr1_82284367_82285219 | 3.93 |
Irs1 |
insulin receptor substrate 1 |
6623 |
0.2 |
chr18_6513819_6514449 | 3.91 |
Epc1 |
enhancer of polycomb homolog 1 |
1974 |
0.29 |
chr17_44731048_44731199 | 3.91 |
Runx2 |
runt related transcription factor 2 |
3570 |
0.21 |
chr6_45062354_45062613 | 3.90 |
Cntnap2 |
contactin associated protein-like 2 |
2422 |
0.26 |
chr5_117241509_117241660 | 3.90 |
Taok3 |
TAO kinase 3 |
1124 |
0.42 |
chr8_123413418_123414506 | 3.89 |
Tubb3 |
tubulin, beta 3 class III |
2372 |
0.11 |
chr3_119498694_119499278 | 3.89 |
Gm23432 |
predicted gene, 23432 |
139888 |
0.05 |
chr5_71093034_71093402 | 3.87 |
Gabra2 |
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 2 |
1422 |
0.6 |
chr4_68953001_68953567 | 3.87 |
Brinp1 |
bone morphogenic protein/retinoic acid inducible neural specific 1 |
1113 |
0.68 |
chr2_96319240_96319943 | 3.85 |
Lrrc4c |
leucine rich repeat containing 4C |
1375 |
0.61 |
chr3_45383303_45383667 | 3.85 |
Pcdh10 |
protocadherin 10 |
852 |
0.56 |
chr6_55678018_55678169 | 3.83 |
Neurod6 |
neurogenic differentiation 6 |
3170 |
0.29 |
chr9_96731522_96733329 | 3.83 |
Zbtb38 |
zinc finger and BTB domain containing 38 |
244 |
0.91 |
chr9_96729464_96730774 | 3.81 |
Zbtb38 |
zinc finger and BTB domain containing 38 |
1083 |
0.47 |
chr19_56725043_56725658 | 3.81 |
Adrb1 |
adrenergic receptor, beta 1 |
1487 |
0.35 |
chr3_4799014_4799414 | 3.81 |
1110015O18Rik |
RIKEN cDNA 1110015O18 gene |
279 |
0.93 |
chr16_50380747_50382000 | 3.79 |
Bbx |
bobby sox HMG box containing |
48539 |
0.18 |
chr14_75962509_75963193 | 3.79 |
Kctd4 |
potassium channel tetramerisation domain containing 4 |
7842 |
0.18 |
chr10_92163758_92164191 | 3.78 |
Rmst |
rhabdomyosarcoma 2 associated transcript (non-coding RNA) |
692 |
0.72 |
chr6_13834624_13835191 | 3.78 |
Gpr85 |
G protein-coupled receptor 85 |
2334 |
0.31 |
chr1_143644977_143645827 | 3.77 |
Cdc73 |
cell division cycle 73, Paf1/RNA polymerase II complex component |
2877 |
0.24 |
chr13_109926306_109927455 | 3.76 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
36 |
0.98 |
chr6_110649216_110650077 | 3.75 |
Gm20387 |
predicted gene 20387 |
3730 |
0.27 |
chr1_139960795_139960946 | 3.75 |
Gm16332 |
predicted gene 16332 |
24393 |
0.13 |
chr2_84648361_84648948 | 3.74 |
Ctnnd1 |
catenin (cadherin associated protein), delta 1 |
117 |
0.92 |
chr8_90957042_90957647 | 3.73 |
Chd9 |
chromodomain helicase DNA binding protein 9 |
1909 |
0.31 |
chrX_20289214_20289472 | 3.72 |
Slc9a7 |
solute carrier family 9 (sodium/hydrogen exchanger), member 7 |
2427 |
0.29 |
chr5_7342068_7342339 | 3.71 |
Zfp804b |
zinc finger protein 804B |
2553 |
0.29 |
chr19_41485012_41485446 | 3.69 |
Lcor |
ligand dependent nuclear receptor corepressor |
2200 |
0.34 |
chr16_77502046_77502387 | 3.68 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
1832 |
0.24 |
chr1_143643975_143644626 | 3.68 |
Cdc73 |
cell division cycle 73, Paf1/RNA polymerase II complex component |
1775 |
0.33 |
chr3_80796675_80796826 | 3.67 |
Gria2 |
glutamate receptor, ionotropic, AMPA2 (alpha 2) |
5829 |
0.28 |
chr18_23807443_23808685 | 3.65 |
Mapre2 |
microtubule-associated protein, RP/EB family, member 2 |
3961 |
0.2 |
chrX_23281963_23282663 | 3.64 |
Klhl13 |
kelch-like 13 |
2516 |
0.41 |
chr3_149444385_149445630 | 3.63 |
Gm30382 |
predicted gene, 30382 |
269 |
0.95 |
chr16_77422348_77423278 | 3.62 |
9430053O09Rik |
RIKEN cDNA 9430053O09 gene |
993 |
0.4 |
chr4_82496503_82496855 | 3.61 |
Nfib |
nuclear factor I/B |
2637 |
0.29 |
chr8_33388198_33388497 | 3.59 |
Purg |
purine-rich element binding protein G |
2022 |
0.32 |
chr16_77420100_77420782 | 3.59 |
9430053O09Rik |
RIKEN cDNA 9430053O09 gene |
1379 |
0.28 |
chr6_91806804_91807812 | 3.58 |
Grip2 |
glutamate receptor interacting protein 2 |
10 |
0.98 |
chr12_107999037_107999696 | 3.57 |
Bcl11b |
B cell leukemia/lymphoma 11B |
4048 |
0.33 |
chr16_42907917_42908393 | 3.57 |
Zbtb20 |
zinc finger and BTB domain containing 20 |
503 |
0.78 |
chr14_64414959_64415137 | 3.57 |
Msra |
methionine sulfoxide reductase A |
1900 |
0.45 |
chr9_43070279_43070559 | 3.56 |
Arhgef12 |
Rho guanine nucleotide exchange factor (GEF) 12 |
27787 |
0.17 |
chr6_25809350_25809884 | 3.55 |
Pot1a |
protection of telomeres 1A |
371 |
0.92 |
chr13_28416755_28419194 | 3.55 |
Gm40841 |
predicted gene, 40841 |
1889 |
0.42 |
chr12_29536509_29537451 | 3.54 |
Myt1l |
myelin transcription factor 1-like |
1758 |
0.36 |
chr13_83987543_83987806 | 3.54 |
Gm4241 |
predicted gene 4241 |
317 |
0.9 |
chr12_88724589_88725423 | 3.52 |
Nrxn3 |
neurexin III |
3 |
0.98 |
chr4_17857165_17857364 | 3.52 |
Mmp16 |
matrix metallopeptidase 16 |
3671 |
0.37 |
chr13_84064321_84064873 | 3.51 |
Gm17750 |
predicted gene, 17750 |
175 |
0.96 |
chr8_45509543_45510137 | 3.51 |
Sorbs2 |
sorbin and SH3 domain containing 2 |
1922 |
0.33 |
chr12_49386539_49386878 | 3.51 |
Gm43517 |
predicted gene 43517 |
1534 |
0.27 |
chr4_145625379_145625530 | 3.50 |
Gm13234 |
predicted gene 13234 |
7050 |
0.1 |
chr18_35212708_35213458 | 3.48 |
Ctnna1 |
catenin (cadherin associated protein), alpha 1 |
1847 |
0.28 |
chr18_33460259_33461386 | 3.48 |
Nrep |
neuronal regeneration related protein |
2613 |
0.29 |
chr1_73961876_73963067 | 3.47 |
Tns1 |
tensin 1 |
572 |
0.8 |
chr1_69085965_69086239 | 3.47 |
Gm16076 |
predicted gene 16076 |
20638 |
0.19 |
chr7_87585537_87585770 | 3.46 |
Grm5 |
glutamate receptor, metabotropic 5 |
1255 |
0.61 |
chr7_49247685_49248635 | 3.46 |
Nav2 |
neuron navigator 2 |
1315 |
0.51 |
chr12_15812207_15812700 | 3.45 |
Trib2 |
tribbles pseudokinase 2 |
4332 |
0.17 |
chrX_103184543_103184694 | 3.44 |
Nap1l2 |
nucleosome assembly protein 1-like 2 |
2022 |
0.23 |
chr18_69597107_69597709 | 3.43 |
Tcf4 |
transcription factor 4 |
2128 |
0.42 |
chr11_37233560_37233902 | 3.42 |
Tenm2 |
teneurin transmembrane protein 2 |
2151 |
0.49 |
chr8_48740124_48740996 | 3.41 |
Tenm3 |
teneurin transmembrane protein 3 |
65870 |
0.13 |
chr12_41485290_41486156 | 3.41 |
Lrrn3 |
leucine rich repeat protein 3, neuronal |
708 |
0.74 |
chrX_23282702_23282891 | 3.40 |
Klhl13 |
kelch-like 13 |
2033 |
0.45 |
chr6_116106085_116106744 | 3.40 |
Gm20404 |
predicted gene 20404 |
1236 |
0.34 |
chr19_19106641_19106954 | 3.38 |
Rorb |
RAR-related orphan receptor beta |
4399 |
0.34 |
chr5_150260534_150260992 | 3.37 |
Fry |
FRY microtubule binding protein |
996 |
0.55 |
chr4_82509049_82510307 | 3.35 |
Gm11266 |
predicted gene 11266 |
1662 |
0.38 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.0 | 23.9 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
5.2 | 15.6 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
4.8 | 14.3 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
4.5 | 18.2 | GO:0060486 | Clara cell differentiation(GO:0060486) |
3.5 | 14.0 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
3.5 | 10.5 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
3.3 | 10.0 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
3.2 | 9.6 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
3.0 | 12.1 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
3.0 | 14.9 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
2.6 | 7.8 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
2.5 | 7.4 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
2.4 | 7.2 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
2.3 | 7.0 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
2.3 | 6.8 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
2.2 | 8.9 | GO:0030091 | protein repair(GO:0030091) |
2.2 | 6.5 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
2.2 | 6.5 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
2.1 | 6.3 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
2.1 | 6.3 | GO:0007525 | somatic muscle development(GO:0007525) |
2.0 | 8.2 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
2.0 | 8.0 | GO:0007258 | JUN phosphorylation(GO:0007258) |
2.0 | 8.0 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
2.0 | 7.9 | GO:0035995 | detection of muscle stretch(GO:0035995) |
1.9 | 5.6 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
1.7 | 5.2 | GO:0046684 | response to pyrethroid(GO:0046684) |
1.7 | 5.2 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
1.7 | 10.3 | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) |
1.7 | 5.1 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
1.7 | 6.8 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
1.7 | 5.0 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
1.7 | 11.6 | GO:0097264 | self proteolysis(GO:0097264) |
1.7 | 6.6 | GO:0003195 | tricuspid valve morphogenesis(GO:0003186) tricuspid valve formation(GO:0003195) |
1.6 | 3.3 | GO:0003284 | septum primum development(GO:0003284) atrial septum primum morphogenesis(GO:0003289) |
1.6 | 8.2 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
1.6 | 9.7 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
1.6 | 17.2 | GO:0097120 | receptor localization to synapse(GO:0097120) |
1.5 | 12.3 | GO:0071625 | vocalization behavior(GO:0071625) |
1.5 | 20.7 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
1.5 | 7.3 | GO:0048496 | maintenance of organ identity(GO:0048496) |
1.4 | 6.9 | GO:1990000 | amyloid fibril formation(GO:1990000) |
1.4 | 4.1 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
1.4 | 10.9 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
1.3 | 5.1 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
1.3 | 3.8 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
1.2 | 6.2 | GO:0090527 | actin filament reorganization(GO:0090527) |
1.2 | 1.2 | GO:0006533 | aspartate catabolic process(GO:0006533) |
1.2 | 3.6 | GO:0050883 | musculoskeletal movement, spinal reflex action(GO:0050883) |
1.2 | 4.8 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
1.2 | 9.4 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
1.2 | 3.5 | GO:0001661 | conditioned taste aversion(GO:0001661) |
1.2 | 3.5 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
1.2 | 5.8 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
1.2 | 11.6 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
1.2 | 1.2 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
1.1 | 3.4 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
1.1 | 3.4 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
1.1 | 4.5 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
1.1 | 4.5 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
1.1 | 17.5 | GO:0060074 | synapse maturation(GO:0060074) |
1.1 | 7.6 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
1.1 | 10.8 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
1.1 | 7.4 | GO:0007638 | mechanosensory behavior(GO:0007638) |
1.1 | 3.2 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
1.0 | 2.1 | GO:0046959 | habituation(GO:0046959) |
1.0 | 4.2 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
1.0 | 2.1 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
1.0 | 1.0 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
1.0 | 1.0 | GO:1901077 | regulation of relaxation of muscle(GO:1901077) |
1.0 | 4.0 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
1.0 | 4.0 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
1.0 | 3.9 | GO:0008228 | opsonization(GO:0008228) |
1.0 | 6.8 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
1.0 | 4.8 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
1.0 | 1.9 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
1.0 | 3.8 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.9 | 2.8 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.9 | 0.9 | GO:0021683 | cerebellar granular layer morphogenesis(GO:0021683) |
0.9 | 8.1 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.9 | 2.7 | GO:0032202 | telomere assembly(GO:0032202) |
0.9 | 1.8 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.9 | 2.7 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.9 | 5.3 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.9 | 4.4 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.9 | 1.7 | GO:2000173 | negative regulation of branching morphogenesis of a nerve(GO:2000173) |
0.9 | 5.1 | GO:0086018 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
0.9 | 2.6 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.8 | 5.1 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.8 | 5.1 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.8 | 1.7 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
0.8 | 16.7 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.8 | 6.5 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.8 | 2.4 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.8 | 0.8 | GO:1902988 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
0.8 | 1.6 | GO:1901629 | regulation of presynaptic membrane organization(GO:1901629) |
0.8 | 7.9 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.8 | 2.4 | GO:0060618 | nipple development(GO:0060618) |
0.8 | 0.8 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.8 | 13.2 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.8 | 0.8 | GO:0071907 | determination of digestive tract left/right asymmetry(GO:0071907) |
0.8 | 0.8 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) |
0.8 | 0.8 | GO:0022009 | central nervous system vasculogenesis(GO:0022009) |
0.8 | 3.1 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.8 | 4.6 | GO:0015074 | DNA integration(GO:0015074) |
0.8 | 2.3 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.8 | 1.5 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
0.8 | 2.3 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.8 | 7.5 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.7 | 3.0 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.7 | 2.2 | GO:0030035 | microspike assembly(GO:0030035) |
0.7 | 1.5 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.7 | 3.0 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.7 | 2.2 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.7 | 4.4 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.7 | 2.9 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.7 | 11.0 | GO:0001964 | startle response(GO:0001964) |
0.7 | 7.3 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.7 | 0.7 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
0.7 | 2.1 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.7 | 5.7 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.7 | 2.8 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.7 | 7.0 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.7 | 3.5 | GO:0007614 | short-term memory(GO:0007614) |
0.7 | 2.1 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.7 | 2.1 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.7 | 0.7 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.7 | 0.7 | GO:1903278 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
0.7 | 2.7 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.7 | 0.7 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.7 | 4.7 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.7 | 0.7 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.7 | 1.3 | GO:0032056 | positive regulation of translation in response to stress(GO:0032056) positive regulation of translational initiation in response to stress(GO:0032058) |
0.7 | 8.0 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.7 | 2.7 | GO:0070671 | response to interleukin-12(GO:0070671) |
0.7 | 2.6 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.7 | 4.0 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.7 | 2.0 | GO:2000850 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.7 | 1.3 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.6 | 1.9 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.6 | 1.3 | GO:0097048 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
0.6 | 1.9 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.6 | 2.5 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.6 | 5.7 | GO:0055119 | relaxation of cardiac muscle(GO:0055119) |
0.6 | 1.3 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.6 | 30.7 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.6 | 3.1 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.6 | 2.5 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.6 | 1.8 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.6 | 3.0 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.6 | 1.8 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.6 | 1.8 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.6 | 3.6 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.6 | 3.0 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.6 | 1.8 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.6 | 1.2 | GO:0010042 | response to manganese ion(GO:0010042) |
0.6 | 8.2 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.6 | 1.2 | GO:0035912 | dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
0.6 | 1.2 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.6 | 1.7 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.6 | 1.7 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.6 | 2.9 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.6 | 0.6 | GO:0007619 | courtship behavior(GO:0007619) |
0.6 | 1.7 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.6 | 0.6 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.6 | 1.7 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.6 | 2.2 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.6 | 2.2 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.6 | 2.2 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.6 | 5.0 | GO:0034331 | cell junction maintenance(GO:0034331) |
0.5 | 9.3 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.5 | 1.6 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
0.5 | 1.1 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.5 | 40.7 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.5 | 1.6 | GO:0042891 | antibiotic transport(GO:0042891) |
0.5 | 3.2 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.5 | 1.6 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.5 | 0.5 | GO:1905065 | positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
0.5 | 1.1 | GO:0071472 | cellular response to salt stress(GO:0071472) |
0.5 | 9.6 | GO:0007616 | long-term memory(GO:0007616) |
0.5 | 1.6 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.5 | 2.1 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.5 | 5.3 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.5 | 1.1 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.5 | 1.6 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
0.5 | 1.6 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.5 | 1.0 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.5 | 0.5 | GO:1905005 | regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
0.5 | 1.6 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.5 | 1.6 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
0.5 | 1.6 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.5 | 1.5 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.5 | 1.5 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.5 | 4.1 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.5 | 1.0 | GO:0090135 | actin filament branching(GO:0090135) |
0.5 | 2.0 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.5 | 6.6 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.5 | 6.1 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.5 | 1.0 | GO:1903416 | response to glycoside(GO:1903416) |
0.5 | 1.5 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.5 | 4.0 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.5 | 2.0 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.5 | 1.5 | GO:0051454 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.5 | 2.0 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.5 | 1.0 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.5 | 1.0 | GO:0021564 | vagus nerve development(GO:0021564) |
0.5 | 1.0 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.5 | 5.3 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.5 | 1.5 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.5 | 1.0 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.5 | 0.5 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.5 | 0.5 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.5 | 3.4 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.5 | 1.9 | GO:0032763 | regulation of mast cell cytokine production(GO:0032763) |
0.5 | 0.5 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.5 | 2.4 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.5 | 2.8 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.5 | 1.4 | GO:1902669 | positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
0.5 | 3.3 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.5 | 9.3 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.5 | 0.5 | GO:0071675 | regulation of mononuclear cell migration(GO:0071675) |
0.5 | 5.1 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.5 | 1.4 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.5 | 2.7 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.5 | 0.9 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.4 | 8.9 | GO:0010107 | potassium ion import(GO:0010107) |
0.4 | 1.3 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.4 | 0.4 | GO:0051665 | membrane raft localization(GO:0051665) |
0.4 | 2.2 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.4 | 3.5 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.4 | 11.3 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.4 | 1.7 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.4 | 0.9 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.4 | 3.9 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.4 | 1.3 | GO:0033026 | negative regulation of mast cell apoptotic process(GO:0033026) |
0.4 | 0.9 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.4 | 0.9 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
0.4 | 8.5 | GO:0019228 | neuronal action potential(GO:0019228) |
0.4 | 1.3 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.4 | 2.1 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.4 | 0.4 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.4 | 0.8 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.4 | 2.1 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.4 | 11.8 | GO:0034605 | cellular response to heat(GO:0034605) |
0.4 | 1.3 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.4 | 2.5 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
0.4 | 0.4 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.4 | 1.7 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.4 | 4.6 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.4 | 4.5 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.4 | 2.5 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.4 | 0.4 | GO:0022028 | tangential migration from the subventricular zone to the olfactory bulb(GO:0022028) |
0.4 | 4.1 | GO:0030575 | nuclear body organization(GO:0030575) |
0.4 | 13.3 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.4 | 1.2 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.4 | 0.4 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.4 | 0.8 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.4 | 0.8 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
0.4 | 3.6 | GO:0097369 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.4 | 0.4 | GO:0032513 | negative regulation of protein phosphatase type 2B activity(GO:0032513) |
0.4 | 0.4 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.4 | 0.4 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.4 | 0.8 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.4 | 1.5 | GO:0071042 | nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.4 | 0.8 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.4 | 1.2 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.4 | 1.1 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.4 | 1.1 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.4 | 5.7 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.4 | 2.6 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.4 | 1.5 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.4 | 1.9 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.4 | 1.9 | GO:1903044 | protein transport into membrane raft(GO:0032596) protein localization to membrane raft(GO:1903044) |
0.4 | 2.2 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.4 | 0.4 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.4 | 1.5 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.4 | 1.1 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.4 | 0.7 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.4 | 2.5 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.4 | 3.3 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.4 | 3.2 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.4 | 0.7 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.4 | 0.7 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.4 | 1.1 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.4 | 1.4 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.4 | 1.4 | GO:0051031 | tRNA transport(GO:0051031) |
0.4 | 1.8 | GO:0016322 | neuron remodeling(GO:0016322) |
0.4 | 1.8 | GO:0010511 | regulation of phosphatidylinositol biosynthetic process(GO:0010511) |
0.4 | 2.1 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.4 | 1.1 | GO:0070445 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
0.3 | 0.3 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.3 | 0.7 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.3 | 3.5 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.3 | 0.7 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.3 | 1.0 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.3 | 22.5 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.3 | 1.4 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.3 | 1.0 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.3 | 0.7 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.3 | 23.0 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.3 | 1.4 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.3 | 1.0 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.3 | 1.7 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.3 | 2.0 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.3 | 1.7 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.3 | 3.0 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.3 | 3.3 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.3 | 1.0 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.3 | 2.3 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.3 | 0.7 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.3 | 2.0 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.3 | 0.7 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.3 | 1.0 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.3 | 2.9 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.3 | 0.3 | GO:0070949 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.3 | 1.0 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.3 | 1.3 | GO:0050812 | regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.3 | 3.2 | GO:0014047 | glutamate secretion(GO:0014047) |
0.3 | 0.6 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.3 | 0.9 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.3 | 0.9 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.3 | 0.9 | GO:0048254 | snoRNA localization(GO:0048254) |
0.3 | 0.9 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.3 | 0.9 | GO:0032429 | regulation of phospholipase A2 activity(GO:0032429) |
0.3 | 1.3 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.3 | 3.8 | GO:0006828 | manganese ion transport(GO:0006828) |
0.3 | 0.9 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.3 | 0.9 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
0.3 | 0.3 | GO:1903671 | negative regulation of sprouting angiogenesis(GO:1903671) |
0.3 | 1.6 | GO:1902307 | positive regulation of sodium ion transmembrane transport(GO:1902307) |
0.3 | 0.9 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.3 | 6.2 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.3 | 0.6 | GO:0044849 | estrous cycle(GO:0044849) |
0.3 | 0.9 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.3 | 0.3 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.3 | 1.2 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.3 | 1.2 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.3 | 0.9 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.3 | 1.2 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.3 | 0.9 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.3 | 0.6 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.3 | 1.8 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.3 | 0.9 | GO:0090148 | membrane fission(GO:0090148) |
0.3 | 0.9 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.3 | 0.9 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.3 | 1.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.3 | 1.2 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.3 | 0.6 | GO:0061047 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.3 | 4.5 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.3 | 1.2 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.3 | 0.3 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.3 | 0.9 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.3 | 2.3 | GO:0046036 | CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
0.3 | 0.9 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.3 | 1.8 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.3 | 0.3 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
0.3 | 0.6 | GO:0072366 | regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.3 | 2.6 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.3 | 1.1 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.3 | 0.9 | GO:0015816 | glycine transport(GO:0015816) |
0.3 | 0.8 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.3 | 0.8 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.3 | 2.0 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.3 | 1.1 | GO:1901660 | calcium ion export(GO:1901660) |
0.3 | 0.6 | GO:0014874 | response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
0.3 | 0.8 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.3 | 0.6 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.3 | 0.3 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.3 | 0.8 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.3 | 2.2 | GO:0097320 | membrane tubulation(GO:0097320) |
0.3 | 0.3 | GO:0070586 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) cell-cell adhesion involved in gastrulation(GO:0070586) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.3 | 0.8 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.3 | 0.8 | GO:0030242 | pexophagy(GO:0030242) |
0.3 | 1.1 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.3 | 6.3 | GO:0006491 | N-glycan processing(GO:0006491) |
0.3 | 1.1 | GO:0034091 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
0.3 | 0.8 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.3 | 1.6 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.3 | 0.5 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.3 | 3.2 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.3 | 1.1 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.3 | 0.8 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.3 | 0.3 | GO:1902590 | viral budding(GO:0046755) multi-organism organelle organization(GO:1902590) multi-organism membrane budding(GO:1902592) |
0.3 | 0.5 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.3 | 2.7 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.3 | 0.8 | GO:0060022 | hard palate development(GO:0060022) |
0.3 | 0.8 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.3 | 0.8 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
0.3 | 1.3 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.3 | 1.1 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.3 | 1.6 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.3 | 1.1 | GO:0046909 | intermembrane transport(GO:0046909) |
0.3 | 1.3 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.3 | 0.3 | GO:0017085 | response to insecticide(GO:0017085) |
0.3 | 1.0 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.3 | 1.3 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.3 | 0.8 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.3 | 1.0 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.3 | 14.9 | GO:0007612 | learning(GO:0007612) |
0.3 | 1.8 | GO:0042220 | response to cocaine(GO:0042220) |
0.3 | 1.0 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.3 | 2.6 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.3 | 1.0 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.3 | 0.8 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.3 | 1.5 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.3 | 0.8 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.3 | 0.8 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.2 | 1.0 | GO:0030913 | paranodal junction assembly(GO:0030913) |
0.2 | 0.2 | GO:0060278 | regulation of ovulation(GO:0060278) |
0.2 | 1.7 | GO:0015824 | proline transport(GO:0015824) |
0.2 | 0.2 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.2 | 0.7 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.2 | 0.5 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.2 | 1.7 | GO:0006108 | malate metabolic process(GO:0006108) |
0.2 | 0.7 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.2 | 0.2 | GO:0032413 | negative regulation of ion transmembrane transporter activity(GO:0032413) |
0.2 | 4.1 | GO:0007628 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.2 | 1.5 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.2 | 0.5 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.2 | 0.7 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.2 | 1.9 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.2 | 0.5 | GO:0030432 | peristalsis(GO:0030432) |
0.2 | 0.5 | GO:0070459 | prolactin secretion(GO:0070459) |
0.2 | 0.5 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.2 | 1.9 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.2 | 1.7 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.2 | 1.4 | GO:0015791 | polyol transport(GO:0015791) |
0.2 | 0.5 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.2 | 0.2 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.2 | 2.6 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.2 | 0.7 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.2 | 0.2 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.2 | 0.9 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.2 | 1.4 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.2 | 4.0 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.2 | 0.7 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.2 | 2.1 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.2 | 0.5 | GO:0008292 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.2 | 0.2 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.2 | 0.5 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.2 | 0.7 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.2 | 2.3 | GO:0036065 | fucosylation(GO:0036065) |
0.2 | 0.2 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.2 | 0.9 | GO:0015867 | ATP transport(GO:0015867) |
0.2 | 1.1 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.2 | 0.2 | GO:0001765 | membrane raft assembly(GO:0001765) |
0.2 | 0.2 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.2 | 5.3 | GO:0031529 | ruffle organization(GO:0031529) |
0.2 | 1.4 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.2 | 0.5 | GO:0061038 | uterus morphogenesis(GO:0061038) |
0.2 | 0.9 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.2 | 0.5 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.2 | 1.1 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.2 | 2.0 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.2 | 0.7 | GO:0019226 | transmission of nerve impulse(GO:0019226) |
0.2 | 0.9 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.2 | 0.4 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.2 | 1.6 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.2 | 0.2 | GO:1902804 | negative regulation of synaptic vesicle transport(GO:1902804) |
0.2 | 0.4 | GO:0050904 | diapedesis(GO:0050904) |
0.2 | 0.7 | GO:0045713 | low-density lipoprotein particle receptor biosynthetic process(GO:0045713) regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
0.2 | 0.9 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.2 | 3.0 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.2 | 2.8 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.2 | 0.2 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
0.2 | 1.1 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.2 | 1.3 | GO:0010889 | regulation of sequestering of triglyceride(GO:0010889) positive regulation of sequestering of triglyceride(GO:0010890) |
0.2 | 0.4 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.2 | 0.2 | GO:0035482 | gastric motility(GO:0035482) |
0.2 | 0.8 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.2 | 0.8 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.2 | 0.4 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.2 | 0.2 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.2 | 0.2 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.2 | 0.2 | GO:0014735 | regulation of muscle atrophy(GO:0014735) |
0.2 | 1.0 | GO:1902031 | regulation of pentose-phosphate shunt(GO:0043456) regulation of NADP metabolic process(GO:1902031) |
0.2 | 0.4 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.2 | 1.2 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.2 | 0.6 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.2 | 2.3 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.2 | 0.6 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.2 | 1.0 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.2 | 0.2 | GO:0061074 | regulation of neural retina development(GO:0061074) regulation of retina development in camera-type eye(GO:1902866) |
0.2 | 0.6 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.2 | 0.6 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.2 | 0.2 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.2 | 0.2 | GO:1901836 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) |
0.2 | 1.4 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.2 | 0.6 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.2 | 0.4 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.2 | 1.0 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.2 | 0.6 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
0.2 | 0.8 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.2 | 1.4 | GO:0048679 | regulation of axon regeneration(GO:0048679) |
0.2 | 0.6 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.2 | 1.0 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.2 | 1.4 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.2 | 0.6 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.2 | 0.4 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.2 | 0.8 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.2 | 0.2 | GO:0038089 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.2 | 3.4 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.2 | 0.4 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.2 | 0.4 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.2 | 0.9 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.2 | 4.5 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.2 | 0.2 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.2 | 0.2 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.2 | 4.1 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.2 | 0.4 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.2 | 0.4 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.2 | 0.5 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.2 | 1.8 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.2 | 0.5 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.2 | 1.2 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.2 | 1.6 | GO:0031269 | pseudopodium assembly(GO:0031269) |
0.2 | 0.4 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.2 | 0.4 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.2 | 0.2 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.2 | 0.4 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.2 | 0.5 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.2 | 4.5 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.2 | 0.5 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.2 | 1.7 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.2 | 0.3 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.2 | 0.9 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.2 | 0.3 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.2 | 1.2 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.2 | 0.3 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.2 | 0.3 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.2 | 0.7 | GO:0035822 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.2 | 0.5 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.2 | 0.7 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.2 | 2.7 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.2 | 0.3 | GO:0090239 | regulation of histone H4 acetylation(GO:0090239) |
0.2 | 0.5 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.2 | 1.5 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.2 | 0.7 | GO:0046629 | gamma-delta T cell activation(GO:0046629) |
0.2 | 0.7 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.2 | 0.3 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.2 | 0.7 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.2 | 0.5 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.2 | 0.2 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
0.2 | 0.5 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.2 | 0.3 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.2 | 0.2 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.2 | 0.6 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.2 | 0.2 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.2 | 0.8 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
0.2 | 0.2 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.2 | 0.3 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.2 | 0.5 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.2 | 0.2 | GO:0032831 | positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.2 | 1.1 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.2 | 0.5 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.2 | 0.3 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.2 | 0.2 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.2 | 0.2 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.2 | 2.0 | GO:0044705 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.2 | 0.3 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
0.1 | 0.6 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 0.7 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 1.2 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.4 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 0.3 | GO:0003096 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.1 | 0.7 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.1 | 0.3 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.1 | 1.9 | GO:0043113 | receptor clustering(GO:0043113) |
0.1 | 0.7 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 0.6 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
0.1 | 3.5 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.1 | 0.4 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.1 | 0.4 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.1 | 0.3 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.1 | 1.0 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.1 | 0.4 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.1 | 0.3 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.1 | 0.6 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.1 | 0.4 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 0.1 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.1 | 0.3 | GO:0009208 | pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) |
0.1 | 0.7 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.1 | 0.1 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.1 | 0.5 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.1 | 0.4 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.1 | 0.3 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 0.1 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.1 | 0.1 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.1 | 0.5 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.1 | 2.2 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.1 | 0.9 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.1 | 1.5 | GO:0006085 | acetyl-CoA biosynthetic process(GO:0006085) |
0.1 | 0.8 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.1 | 0.7 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 2.9 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.1 | 0.3 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) dermatan sulfate biosynthetic process(GO:0030208) |
0.1 | 1.0 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 1.0 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 0.4 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.1 | 0.8 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.1 | 9.6 | GO:0000910 | cytokinesis(GO:0000910) |
0.1 | 0.3 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.1 | 0.6 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.1 | 0.6 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.1 | 0.4 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.1 | 0.4 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.1 | 1.8 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.1 | 0.4 | GO:0046078 | dUMP metabolic process(GO:0046078) |
0.1 | 0.6 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.1 | 0.4 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.1 | 0.1 | GO:0048865 | stem cell fate commitment(GO:0048865) |
0.1 | 0.4 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.1 | 0.5 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
0.1 | 0.6 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.1 | 0.7 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.1 | 0.5 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.1 | 0.2 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.1 | 0.5 | GO:0061590 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.1 | 0.4 | GO:0015888 | thiamine transport(GO:0015888) |
0.1 | 1.0 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.4 | GO:1900040 | regulation of interleukin-2 secretion(GO:1900040) |
0.1 | 0.1 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.1 | 0.1 | GO:1903115 | regulation of actin filament-based movement(GO:1903115) |
0.1 | 0.2 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.1 | 0.7 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.1 | 0.2 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.1 | 0.1 | GO:0033024 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
0.1 | 0.1 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.1 | 1.8 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.1 | 0.5 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.1 | 0.5 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.1 | 0.5 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.1 | 0.7 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.2 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.1 | 0.2 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.1 | 0.8 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.1 | 0.2 | GO:0048242 | epinephrine secretion(GO:0048242) |
0.1 | 0.5 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.1 | 0.1 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.1 | 0.3 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 0.3 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.1 | 0.2 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.1 | 4.1 | GO:0007566 | embryo implantation(GO:0007566) |
0.1 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 0.5 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.1 | 0.8 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 0.1 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.1 | 0.7 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.1 | 0.2 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 1.3 | GO:0043368 | positive T cell selection(GO:0043368) |
0.1 | 0.2 | GO:0006868 | glutamine transport(GO:0006868) |
0.1 | 0.3 | GO:0042756 | drinking behavior(GO:0042756) |
0.1 | 0.5 | GO:0031000 | response to caffeine(GO:0031000) |
0.1 | 0.4 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.1 | 1.9 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.1 | 0.4 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.1 | 1.4 | GO:0030449 | regulation of complement activation(GO:0030449) |
0.1 | 0.1 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.1 | 0.1 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.1 | 0.3 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 0.9 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.1 | 0.1 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.1 | 0.2 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.1 | 1.1 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.1 | 1.1 | GO:0006743 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) |
0.1 | 0.4 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.1 | 0.3 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.1 | 0.1 | GO:1900044 | regulation of protein K63-linked ubiquitination(GO:1900044) |
0.1 | 0.1 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.1 | 0.3 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.1 | 0.7 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.6 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.1 | 0.2 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.1 | 0.3 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.7 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.1 | 1.7 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.1 | 0.4 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.1 | 0.3 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.1 | 0.5 | GO:0000467 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.1 | 0.5 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.1 | 0.1 | GO:0060123 | regulation of growth hormone secretion(GO:0060123) |
0.1 | 0.2 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.1 | 0.4 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.1 | 0.2 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.1 | 2.5 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.1 | GO:0044090 | positive regulation of vacuole organization(GO:0044090) |
0.1 | 0.4 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
0.1 | 0.4 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.1 | 0.1 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.1 | 0.2 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.1 | 0.1 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.1 | 0.4 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.1 | 0.2 | GO:0051938 | L-glutamate import(GO:0051938) |
0.1 | 0.3 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.1 | 0.2 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.1 | 0.3 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.1 | 0.2 | GO:0002838 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
0.1 | 0.2 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.1 | 0.9 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 1.6 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.1 | 0.7 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.1 | 0.1 | GO:0015817 | histidine transport(GO:0015817) |
0.1 | 0.1 | GO:0009148 | pyrimidine nucleoside triphosphate biosynthetic process(GO:0009148) |
0.1 | 1.0 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.1 | 0.3 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.1 | 0.2 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.1 | 0.5 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.3 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 1.1 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.1 | 0.4 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.1 | 0.4 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 0.3 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.1 | 0.3 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.1 | 0.2 | GO:0035425 | autocrine signaling(GO:0035425) |
0.1 | 0.7 | GO:0000338 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.1 | 0.3 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 0.1 | GO:0046689 | response to mercury ion(GO:0046689) |
0.1 | 0.3 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.1 | 0.5 | GO:0046847 | filopodium assembly(GO:0046847) |
0.1 | 0.7 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.1 | 0.2 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.1 | 0.2 | GO:0060005 | vestibular reflex(GO:0060005) |
0.1 | 0.2 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.1 | 0.2 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.1 | 0.4 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 0.5 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.1 | 0.3 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 1.8 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
0.1 | 0.2 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.1 | 0.2 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.1 | 0.2 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.1 | 0.2 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.1 | 0.2 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.1 | 0.2 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.6 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 1.8 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
0.1 | 0.1 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
0.1 | 0.3 | GO:0035627 | ceramide transport(GO:0035627) |
0.1 | 0.1 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 0.3 | GO:1905145 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.1 | 0.2 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.1 | 0.2 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.1 | 0.2 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.1 | 0.3 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.1 | 0.1 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 0.1 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.1 | 0.7 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 0.1 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.1 | 0.1 | GO:0002676 | regulation of chronic inflammatory response(GO:0002676) |
0.1 | 0.1 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.1 | 0.2 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.1 | 1.7 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.1 | 0.4 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.1 | 0.2 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.1 | 0.5 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.1 | 0.7 | GO:0009303 | rRNA transcription(GO:0009303) |
0.1 | 0.1 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.1 | 0.1 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 | 0.1 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.1 | 0.3 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.1 | 0.3 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.7 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.1 | 0.2 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.1 | 0.2 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.1 | 0.3 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.1 | 0.1 | GO:0072338 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.1 | 4.4 | GO:0098792 | xenophagy(GO:0098792) |
0.1 | 0.7 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.1 | 0.1 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.1 | 0.5 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.1 | 0.1 | GO:0003160 | endocardium morphogenesis(GO:0003160) |
0.1 | 0.8 | GO:0033081 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.1 | 0.1 | GO:0045343 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.1 | 0.4 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.3 | GO:1902803 | regulation of synaptic vesicle transport(GO:1902803) |
0.1 | 0.2 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.1 | 0.7 | GO:0046688 | response to copper ion(GO:0046688) |
0.1 | 6.6 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.1 | 0.1 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.1 | 0.5 | GO:0072384 | organelle transport along microtubule(GO:0072384) |
0.1 | 0.8 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.1 | 0.5 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.1 | 0.2 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
0.1 | 0.4 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.3 | GO:1904357 | negative regulation of telomere maintenance via telomere lengthening(GO:1904357) |
0.1 | 0.1 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.1 | 0.1 | GO:1901535 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.1 | 0.4 | GO:0042119 | neutrophil activation(GO:0042119) |
0.1 | 0.3 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.1 | 0.1 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.1 | 0.1 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 0.3 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.1 | 1.0 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.1 | 0.2 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.1 | 2.1 | GO:0001505 | regulation of neurotransmitter levels(GO:0001505) |
0.1 | 0.1 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.1 | 0.2 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.1 | 0.3 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 0.3 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.1 | 0.2 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.3 | GO:0002467 | germinal center formation(GO:0002467) |
0.1 | 0.1 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.1 | 1.1 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.1 | 0.1 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.1 | 0.6 | GO:0045187 | regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
0.1 | 0.1 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.1 | 0.1 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 0.1 | GO:0016237 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) single-organism membrane invagination(GO:1902534) |
0.1 | 0.2 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.1 | 2.9 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.1 | 0.7 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.1 | 0.1 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.1 | 0.1 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) regulation of sodium-dependent phosphate transport(GO:2000118) |
0.1 | 0.1 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.1 | 0.2 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.1 | 0.1 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.1 | 0.1 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.1 | 1.9 | GO:0030705 | cytoskeleton-dependent intracellular transport(GO:0030705) |
0.1 | 0.2 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.1 | 0.4 | GO:0045056 | transcytosis(GO:0045056) |
0.1 | 0.8 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.1 | 0.3 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.1 | 0.1 | GO:2000667 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.1 | 0.1 | GO:0034969 | histone arginine methylation(GO:0034969) |
0.1 | 0.4 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 0.3 | GO:0031113 | regulation of microtubule polymerization(GO:0031113) |
0.1 | 0.2 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) |
0.1 | 0.3 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.1 | 0.2 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.1 | 0.1 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.1 | 0.1 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
0.1 | 0.1 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
0.1 | 0.2 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 0.2 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.1 | 0.1 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.1 | 0.7 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.1 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.0 | 0.0 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.0 | 0.2 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 0.1 | GO:0072610 | interleukin-12 secretion(GO:0072610) |
0.0 | 1.9 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.0 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.0 | 0.0 | GO:1901663 | quinone biosynthetic process(GO:1901663) |
0.0 | 0.1 | GO:0032607 | interferon-alpha production(GO:0032607) |
0.0 | 0.1 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.0 | 0.1 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.0 | 0.4 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.0 | 0.5 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.0 | 0.6 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.0 | 0.1 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.0 | 0.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.0 | GO:0042522 | regulation of tyrosine phosphorylation of Stat5 protein(GO:0042522) |
0.0 | 0.1 | GO:0006837 | serotonin transport(GO:0006837) |
0.0 | 0.0 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.0 | 0.4 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.0 | 0.2 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.0 | 0.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.0 | 0.2 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.0 | 0.0 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
0.0 | 0.5 | GO:0030033 | microvillus assembly(GO:0030033) |
0.0 | 0.1 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.0 | 0.1 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.0 | 0.1 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.0 | 0.0 | GO:0033240 | positive regulation of cellular amine metabolic process(GO:0033240) |
0.0 | 0.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.0 | 0.0 | GO:0070316 | G0 to G1 transition(GO:0045023) regulation of G0 to G1 transition(GO:0070316) |
0.0 | 0.0 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.0 | 0.2 | GO:0002021 | response to dietary excess(GO:0002021) |
0.0 | 0.2 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.0 | 0.1 | GO:0032328 | alanine transport(GO:0032328) |
0.0 | 0.2 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.0 | 1.5 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.0 | GO:0070640 | vitamin D3 metabolic process(GO:0070640) |
0.0 | 0.1 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.0 | 0.0 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.0 | 0.0 | GO:0018377 | protein myristoylation(GO:0018377) |
0.0 | 0.1 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.0 | 0.0 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.0 | 0.3 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.0 | 0.1 | GO:0006273 | lagging strand elongation(GO:0006273) |
0.0 | 0.0 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.0 | 0.1 | GO:0080009 | mRNA methylation(GO:0080009) |
0.0 | 0.0 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.0 | 0.5 | GO:0042461 | photoreceptor cell development(GO:0042461) |
0.0 | 0.0 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.0 | 0.1 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.0 | 0.0 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.4 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.0 | 0.2 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.0 | 0.6 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.0 | 0.1 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.0 | 0.0 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 0.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.0 | 0.7 | GO:0032091 | negative regulation of protein binding(GO:0032091) |
0.0 | 0.1 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.0 | 0.0 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
0.0 | 0.0 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.0 | 0.0 | GO:0036005 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.0 | 0.1 | GO:0046931 | pore complex assembly(GO:0046931) |
0.0 | 0.1 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.0 | 0.1 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.0 | 0.1 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.0 | 0.1 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.0 | 0.1 | GO:0009197 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.0 | 0.1 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.0 | 0.0 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.0 | 0.1 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.0 | 0.1 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) |
0.0 | 0.7 | GO:0042775 | mitochondrial ATP synthesis coupled electron transport(GO:0042775) |
0.0 | 0.1 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.0 | 0.2 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.0 | 0.3 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.0 | 0.0 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.0 | 0.2 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
0.0 | 0.1 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.0 | 0.4 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.0 | 0.0 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.0 | 0.2 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.0 | 0.3 | GO:0010524 | positive regulation of calcium ion transport into cytosol(GO:0010524) |
0.0 | 0.1 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.0 | 0.1 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.0 | 0.0 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.0 | 0.2 | GO:0055069 | zinc ion homeostasis(GO:0055069) |
0.0 | 0.2 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.0 | 0.1 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
0.0 | 0.0 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.0 | 0.0 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.0 | 0.2 | GO:0002347 | response to tumor cell(GO:0002347) |
0.0 | 0.2 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.0 | 0.0 | GO:0046831 | regulation of nucleobase-containing compound transport(GO:0032239) regulation of RNA export from nucleus(GO:0046831) |
0.0 | 0.0 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.0 | 0.1 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.0 | 0.0 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.0 | 0.2 | GO:0006415 | translational termination(GO:0006415) |
0.0 | 0.2 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.0 | 0.3 | GO:0045777 | positive regulation of blood pressure(GO:0045777) |
0.0 | 0.0 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
0.0 | 0.0 | GO:0070842 | aggresome assembly(GO:0070842) |
0.0 | 0.0 | GO:1903059 | regulation of protein lipidation(GO:1903059) |
0.0 | 0.0 | GO:0006522 | alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) L-alanine metabolic process(GO:0042851) |
0.0 | 0.1 | GO:0002934 | desmosome organization(GO:0002934) |
0.0 | 0.2 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.0 | 0.1 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.0 | 0.1 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.0 | 0.1 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.0 | 0.1 | GO:0051189 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.0 | 0.1 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.0 | 0.0 | GO:0072584 | caveolin-mediated endocytosis(GO:0072584) |
0.0 | 0.0 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.0 | 0.0 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.0 | 0.0 | GO:0048241 | epinephrine transport(GO:0048241) |
0.0 | 0.0 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.0 | 0.0 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.0 | 0.0 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
0.0 | 0.1 | GO:0031294 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.0 | 0.0 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.0 | 0.0 | GO:0010692 | regulation of alkaline phosphatase activity(GO:0010692) |
0.0 | 0.0 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.0 | GO:0007320 | insemination(GO:0007320) |
0.0 | 0.1 | GO:0080111 | DNA demethylation(GO:0080111) |
0.0 | 0.0 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.0 | 0.0 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.0 | 0.0 | GO:2000641 | regulation of early endosome to late endosome transport(GO:2000641) |
0.0 | 0.0 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.0 | 0.0 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.0 | 0.0 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.0 | 0.0 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.0 | 0.0 | GO:2001273 | glucose import in response to insulin stimulus(GO:0044381) regulation of glucose import in response to insulin stimulus(GO:2001273) |
0.0 | 0.0 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.0 | 0.0 | GO:0032650 | regulation of interleukin-1 alpha production(GO:0032650) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.8 | 14.4 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
3.1 | 9.3 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
3.0 | 23.7 | GO:0043083 | synaptic cleft(GO:0043083) |
2.3 | 16.1 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
1.6 | 6.3 | GO:1990696 | USH2 complex(GO:1990696) |
1.6 | 7.8 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
1.5 | 9.0 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
1.5 | 5.9 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
1.5 | 14.7 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
1.4 | 4.3 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
1.4 | 11.5 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
1.4 | 1.4 | GO:0044294 | dendritic growth cone(GO:0044294) |
1.4 | 12.3 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.4 | 9.5 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
1.3 | 8.1 | GO:0005915 | zonula adherens(GO:0005915) |
1.3 | 1.3 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
1.2 | 13.5 | GO:0097449 | astrocyte projection(GO:0097449) |
1.2 | 18.1 | GO:0031527 | filopodium membrane(GO:0031527) |
1.2 | 32.2 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
1.2 | 10.6 | GO:0005859 | muscle myosin complex(GO:0005859) |
1.1 | 6.9 | GO:0032591 | dendritic spine membrane(GO:0032591) |
1.1 | 21.4 | GO:0060077 | inhibitory synapse(GO:0060077) |
1.0 | 22.0 | GO:0048786 | presynaptic active zone(GO:0048786) |
1.0 | 44.9 | GO:0043198 | dendritic shaft(GO:0043198) |
1.0 | 6.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
1.0 | 3.0 | GO:0072534 | perineuronal net(GO:0072534) |
1.0 | 32.5 | GO:0042734 | presynaptic membrane(GO:0042734) |
1.0 | 2.9 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.9 | 7.6 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.9 | 2.7 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.9 | 4.5 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.9 | 5.2 | GO:0031430 | M band(GO:0031430) |
0.9 | 2.6 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.9 | 12.1 | GO:0031045 | dense core granule(GO:0031045) |
0.9 | 10.4 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.9 | 1.7 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.8 | 4.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.8 | 4.0 | GO:0097433 | dense body(GO:0097433) |
0.8 | 6.3 | GO:0034464 | BBSome(GO:0034464) |
0.7 | 2.9 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.7 | 2.0 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.7 | 2.0 | GO:0043511 | inhibin complex(GO:0043511) |
0.7 | 12.4 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.6 | 3.8 | GO:0030673 | axolemma(GO:0030673) |
0.6 | 1.8 | GO:0005745 | m-AAA complex(GO:0005745) |
0.6 | 1.8 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.6 | 1.2 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.6 | 1.8 | GO:0097513 | myosin II filament(GO:0097513) |
0.6 | 3.4 | GO:0032584 | growth cone membrane(GO:0032584) |
0.6 | 33.6 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.6 | 2.8 | GO:0043194 | axon initial segment(GO:0043194) |
0.6 | 1.7 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.5 | 4.9 | GO:0005916 | fascia adherens(GO:0005916) |
0.5 | 2.2 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.5 | 9.7 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.5 | 1.6 | GO:0031417 | NatC complex(GO:0031417) |
0.5 | 1.6 | GO:0097443 | sorting endosome(GO:0097443) |
0.5 | 2.6 | GO:0032590 | dendrite membrane(GO:0032590) |
0.5 | 31.2 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.5 | 3.6 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.5 | 13.0 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.5 | 6.0 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.5 | 0.5 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
0.5 | 1.0 | GO:0097441 | basilar dendrite(GO:0097441) |
0.5 | 19.1 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.5 | 17.6 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.5 | 4.7 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.5 | 4.7 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.5 | 8.8 | GO:0044295 | axonal growth cone(GO:0044295) |
0.4 | 6.3 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.4 | 2.7 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.4 | 57.1 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.4 | 7.1 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.4 | 0.9 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.4 | 3.0 | GO:0097440 | apical dendrite(GO:0097440) |
0.4 | 1.7 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.4 | 2.6 | GO:0098645 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.4 | 1.3 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.4 | 7.3 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.4 | 34.9 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.4 | 5.5 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.4 | 0.8 | GO:0032280 | symmetric synapse(GO:0032280) |
0.4 | 2.5 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.4 | 1.6 | GO:0005883 | neurofilament(GO:0005883) |
0.4 | 2.8 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.4 | 2.6 | GO:0070187 | telosome(GO:0070187) |
0.4 | 1.9 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.4 | 1.9 | GO:0042587 | glycogen granule(GO:0042587) |
0.4 | 20.7 | GO:0031674 | I band(GO:0031674) |
0.4 | 1.4 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.4 | 1.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.4 | 3.5 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.4 | 25.6 | GO:0030427 | site of polarized growth(GO:0030427) |
0.3 | 1.4 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.3 | 2.4 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.3 | 0.7 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.3 | 0.3 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.3 | 3.0 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.3 | 0.3 | GO:1990357 | terminal web(GO:1990357) |
0.3 | 0.6 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.3 | 5.1 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.3 | 0.9 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.3 | 0.9 | GO:0043196 | varicosity(GO:0043196) |
0.3 | 3.5 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.3 | 0.9 | GO:0097386 | glial cell projection(GO:0097386) |
0.3 | 1.7 | GO:0031143 | pseudopodium(GO:0031143) |
0.3 | 0.3 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.3 | 1.7 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.3 | 0.3 | GO:0005955 | calcineurin complex(GO:0005955) |
0.3 | 2.9 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.3 | 0.5 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.3 | 3.7 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.3 | 0.8 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.2 | 0.5 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.2 | 1.0 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.2 | 3.4 | GO:0071565 | nBAF complex(GO:0071565) |
0.2 | 1.2 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.2 | 1.2 | GO:0070695 | FHF complex(GO:0070695) |
0.2 | 1.0 | GO:0061574 | ASAP complex(GO:0061574) |
0.2 | 0.7 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.2 | 1.7 | GO:0031931 | TORC1 complex(GO:0031931) |
0.2 | 0.5 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.2 | 0.7 | GO:0043293 | apoptosome(GO:0043293) |
0.2 | 3.5 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 3.0 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.2 | 0.5 | GO:0016460 | myosin II complex(GO:0016460) |
0.2 | 0.5 | GO:0042585 | germinal vesicle(GO:0042585) |
0.2 | 2.0 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.2 | 0.9 | GO:0035363 | histone locus body(GO:0035363) |
0.2 | 1.3 | GO:0031902 | late endosome membrane(GO:0031902) |
0.2 | 0.9 | GO:0032009 | early phagosome(GO:0032009) |
0.2 | 1.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.2 | 0.9 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.2 | 0.4 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.2 | 1.0 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.2 | 0.2 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.2 | 1.2 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.2 | 0.2 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.2 | 0.6 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.2 | 6.0 | GO:0043197 | dendritic spine(GO:0043197) |
0.2 | 1.4 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.2 | 2.8 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.2 | 0.6 | GO:0070552 | BRISC complex(GO:0070552) |
0.2 | 1.4 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.2 | 0.2 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.2 | 1.7 | GO:0034704 | calcium channel complex(GO:0034704) |
0.2 | 1.3 | GO:0033263 | CORVET complex(GO:0033263) |
0.2 | 4.4 | GO:0032420 | stereocilium(GO:0032420) |
0.2 | 1.7 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.2 | 1.3 | GO:0005605 | basal lamina(GO:0005605) |
0.2 | 0.4 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.2 | 3.6 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.2 | 0.7 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.2 | 7.2 | GO:0044853 | plasma membrane raft(GO:0044853) |
0.2 | 0.5 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.2 | 0.9 | GO:0000805 | X chromosome(GO:0000805) |
0.2 | 0.9 | GO:0044292 | dendrite terminus(GO:0044292) |
0.2 | 4.5 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.2 | 0.3 | GO:0055087 | Ski complex(GO:0055087) |
0.2 | 4.7 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.2 | 0.8 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.2 | 2.3 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.2 | 1.3 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.2 | 1.0 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.2 | 0.6 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.2 | 1.1 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.2 | 0.6 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.2 | 0.2 | GO:0000938 | GARP complex(GO:0000938) |
0.2 | 0.2 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.2 | 4.9 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.2 | 1.4 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.2 | 0.3 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.2 | 1.2 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.2 | 5.1 | GO:0016459 | myosin complex(GO:0016459) |
0.2 | 20.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.2 | 1.2 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.2 | 1.4 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.2 | 0.5 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 1.9 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.1 | 1.3 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 8.5 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 29.5 | GO:0045202 | synapse(GO:0045202) |
0.1 | 1.6 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 2.2 | GO:0043679 | axon terminus(GO:0043679) |
0.1 | 0.6 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.1 | 1.0 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.5 | GO:1990130 | Iml1 complex(GO:1990130) |
0.1 | 0.9 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.1 | 1.3 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.1 | 1.6 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 13.6 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 0.8 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.1 | 0.5 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 0.6 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 0.4 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.1 | 1.1 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 0.7 | GO:0070847 | core mediator complex(GO:0070847) |
0.1 | 0.4 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 0.4 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 1.2 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 0.5 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.1 | 0.7 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 2.0 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.1 | 0.5 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 1.7 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.1 | 0.1 | GO:0000322 | storage vacuole(GO:0000322) |
0.1 | 1.6 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.3 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.1 | 0.9 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 0.2 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 0.8 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 1.1 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 0.3 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 0.3 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.1 | 0.3 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.1 | 0.3 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 0.1 | GO:0043657 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.1 | 2.5 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 1.0 | GO:0031011 | Ino80 complex(GO:0031011) |
0.1 | 0.3 | GO:0042583 | chromaffin granule(GO:0042583) |
0.1 | 0.3 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 0.5 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 0.4 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.1 | 0.3 | GO:1990462 | omegasome(GO:1990462) |
0.1 | 0.3 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 1.9 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 0.6 | GO:0044304 | main axon(GO:0044304) |
0.1 | 3.9 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.7 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 0.6 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 0.3 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.1 | 4.7 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 0.4 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 0.3 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 1.0 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 0.2 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 0.4 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 1.0 | GO:0097546 | ciliary base(GO:0097546) |
0.1 | 1.3 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.2 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 0.5 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.1 | 0.7 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 1.3 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 0.7 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 0.6 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 1.6 | GO:0042383 | sarcolemma(GO:0042383) |
0.1 | 0.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.2 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.1 | 1.3 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.1 | 0.3 | GO:0002177 | manchette(GO:0002177) |
0.1 | 0.9 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.1 | 8.2 | GO:0030425 | dendrite(GO:0030425) |
0.1 | 0.2 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.8 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 3.2 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.1 | 1.3 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 0.5 | GO:0005861 | troponin complex(GO:0005861) |
0.1 | 0.2 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 0.1 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 0.1 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 0.1 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.1 | 0.2 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.1 | 2.6 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.1 | 0.4 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.1 | 0.7 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 0.9 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.1 | 0.5 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 2.0 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 0.6 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 3.8 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 1.1 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.1 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.3 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.0 | 0.7 | GO:0031901 | early endosome membrane(GO:0031901) |
0.0 | 0.4 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.0 | 3.0 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 0.3 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.0 | 0.1 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.0 | 0.2 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.0 | 0.1 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.0 | 0.0 | GO:0097413 | Lewy body(GO:0097413) |
0.0 | 0.6 | GO:0031513 | nonmotile primary cilium(GO:0031513) |
0.0 | 0.1 | GO:0030689 | Noc complex(GO:0030689) |
0.0 | 0.2 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 0.8 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 0.1 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.0 | 0.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.8 | GO:0032040 | small-subunit processome(GO:0032040) |
0.0 | 0.2 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 0.2 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 7.5 | GO:0097458 | neuron part(GO:0097458) |
0.0 | 0.0 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.0 | 0.1 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.0 | 0.0 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.0 | 0.1 | GO:0071953 | elastic fiber(GO:0071953) |
0.0 | 0.4 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.0 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.0 | 0.0 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.0 | 0.1 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.3 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.0 | 0.1 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.0 | 0.1 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 0.4 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 0.1 | GO:0032797 | SMN complex(GO:0032797) |
0.0 | 0.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 0.1 | GO:0000801 | central element(GO:0000801) |
0.0 | 0.1 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 0.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.3 | 24.9 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
3.5 | 10.5 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
3.1 | 6.1 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
3.0 | 23.6 | GO:0002162 | dystroglycan binding(GO:0002162) |
2.9 | 5.7 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
2.5 | 12.3 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
2.4 | 7.3 | GO:0050816 | phosphothreonine binding(GO:0050816) |
2.4 | 7.3 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
2.4 | 9.6 | GO:0031433 | telethonin binding(GO:0031433) |
2.3 | 9.1 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
2.2 | 8.9 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
2.2 | 6.5 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
1.9 | 11.3 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
1.9 | 7.4 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
1.8 | 15.8 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
1.8 | 5.3 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
1.7 | 5.0 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
1.6 | 8.2 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
1.6 | 6.5 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
1.6 | 6.3 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
1.5 | 13.6 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
1.5 | 10.3 | GO:0003680 | AT DNA binding(GO:0003680) |
1.4 | 4.2 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
1.4 | 15.1 | GO:0042043 | neurexin family protein binding(GO:0042043) |
1.4 | 2.7 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
1.3 | 6.6 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
1.3 | 7.8 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
1.3 | 3.8 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
1.3 | 27.6 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
1.2 | 7.2 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
1.2 | 3.6 | GO:0016842 | amidine-lyase activity(GO:0016842) |
1.1 | 3.4 | GO:0035939 | microsatellite binding(GO:0035939) |
1.1 | 2.3 | GO:0045503 | dynein light chain binding(GO:0045503) |
1.1 | 4.6 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
1.1 | 9.0 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
1.1 | 4.3 | GO:0008502 | melatonin receptor activity(GO:0008502) |
1.1 | 5.3 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
1.1 | 3.2 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
1.0 | 7.3 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
1.0 | 3.1 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
1.0 | 6.2 | GO:0004385 | guanylate kinase activity(GO:0004385) |
1.0 | 2.9 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.9 | 6.6 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.9 | 2.8 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.9 | 10.3 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.9 | 3.7 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.9 | 7.1 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.9 | 3.6 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.9 | 3.5 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.9 | 1.8 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.9 | 18.2 | GO:0031420 | alkali metal ion binding(GO:0031420) |
0.9 | 3.4 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.9 | 2.6 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.8 | 4.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.8 | 5.8 | GO:0043495 | protein anchor(GO:0043495) |
0.8 | 2.5 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.8 | 6.6 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.8 | 3.3 | GO:0031013 | troponin I binding(GO:0031013) |
0.8 | 2.4 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.8 | 4.6 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.7 | 3.7 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.7 | 1.5 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.7 | 1.5 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.7 | 2.2 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.7 | 8.6 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.7 | 8.6 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.7 | 2.0 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.7 | 3.9 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.7 | 3.3 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.6 | 6.4 | GO:0051378 | serotonin binding(GO:0051378) |
0.6 | 1.9 | GO:0071253 | connexin binding(GO:0071253) |
0.6 | 2.6 | GO:0070052 | collagen V binding(GO:0070052) |
0.6 | 0.6 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.6 | 1.9 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.6 | 3.2 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.6 | 1.9 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.6 | 1.9 | GO:0004359 | glutaminase activity(GO:0004359) |
0.6 | 3.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.6 | 3.1 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.6 | 7.4 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.6 | 1.9 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.6 | 0.6 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.6 | 18.4 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.6 | 2.5 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.6 | 4.3 | GO:0031432 | titin binding(GO:0031432) |
0.6 | 13.9 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.6 | 1.8 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.6 | 10.3 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.6 | 8.9 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.6 | 1.8 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.6 | 4.1 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.6 | 5.2 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.6 | 1.7 | GO:0001032 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.6 | 5.2 | GO:0017166 | vinculin binding(GO:0017166) |
0.6 | 1.7 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.6 | 10.5 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.6 | 1.7 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.5 | 1.1 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.5 | 1.6 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.5 | 2.1 | GO:0030274 | LIM domain binding(GO:0030274) |
0.5 | 5.3 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.5 | 2.1 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.5 | 2.7 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.5 | 2.7 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.5 | 1.0 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.5 | 1.0 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.5 | 1.0 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.5 | 8.3 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.5 | 1.0 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.5 | 1.5 | GO:2001070 | starch binding(GO:2001070) |
0.5 | 1.0 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.5 | 2.0 | GO:0043426 | MRF binding(GO:0043426) |
0.5 | 2.5 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.5 | 4.9 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.5 | 1.0 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.5 | 9.7 | GO:0003785 | actin monomer binding(GO:0003785) |
0.5 | 8.2 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.5 | 5.3 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.5 | 2.9 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.5 | 3.8 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.5 | 36.3 | GO:0044325 | ion channel binding(GO:0044325) |
0.5 | 5.6 | GO:0030552 | cAMP binding(GO:0030552) |
0.5 | 6.4 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.5 | 1.4 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.4 | 0.4 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.4 | 1.3 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.4 | 1.8 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.4 | 4.4 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.4 | 2.2 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.4 | 1.3 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.4 | 6.0 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.4 | 2.1 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.4 | 6.8 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.4 | 2.5 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.4 | 1.3 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.4 | 1.2 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.4 | 0.8 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.4 | 1.2 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.4 | 1.6 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.4 | 1.6 | GO:0034046 | poly(G) binding(GO:0034046) |
0.4 | 2.0 | GO:0018498 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.4 | 4.0 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.4 | 0.8 | GO:0033265 | choline binding(GO:0033265) |
0.4 | 2.3 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.4 | 2.0 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.4 | 4.3 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.4 | 5.1 | GO:0031005 | filamin binding(GO:0031005) |
0.4 | 2.3 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.4 | 1.1 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.4 | 4.5 | GO:0044213 | intronic transcription regulatory region DNA binding(GO:0044213) |
0.4 | 7.6 | GO:0042805 | actinin binding(GO:0042805) |
0.4 | 0.8 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.4 | 3.4 | GO:0005522 | profilin binding(GO:0005522) |
0.4 | 1.5 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.4 | 7.8 | GO:0045296 | cadherin binding(GO:0045296) |
0.4 | 0.4 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.4 | 4.5 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.4 | 1.5 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.4 | 1.8 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.4 | 0.7 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.4 | 3.6 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.4 | 0.7 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.3 | 4.9 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.3 | 1.0 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.3 | 0.3 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.3 | 5.1 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.3 | 3.4 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.3 | 1.0 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.3 | 1.7 | GO:0044548 | S100 protein binding(GO:0044548) |
0.3 | 5.3 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.3 | 1.3 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.3 | 21.5 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.3 | 1.6 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.3 | 1.3 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.3 | 1.6 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.3 | 1.6 | GO:0016775 | phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.3 | 0.6 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.3 | 6.3 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.3 | 0.3 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.3 | 0.6 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.3 | 1.2 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.3 | 0.9 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.3 | 0.9 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.3 | 3.7 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.3 | 0.9 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.3 | 1.5 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.3 | 0.9 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.3 | 0.9 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.3 | 6.3 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.3 | 0.9 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.3 | 0.9 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.3 | 3.0 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.3 | 1.2 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.3 | 0.3 | GO:0051425 | PTB domain binding(GO:0051425) |
0.3 | 0.9 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.3 | 0.6 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.3 | 1.5 | GO:0070728 | leucine binding(GO:0070728) |
0.3 | 0.9 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.3 | 2.9 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.3 | 2.9 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.3 | 3.8 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.3 | 0.3 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.3 | 1.4 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.3 | 1.4 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.3 | 2.9 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.3 | 1.7 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.3 | 1.7 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.3 | 1.4 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.3 | 1.1 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.3 | 0.8 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.3 | 2.2 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.3 | 1.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.3 | 1.4 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.3 | 0.8 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.3 | 3.5 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.3 | 1.6 | GO:0034791 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.3 | 2.2 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.3 | 2.4 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.3 | 1.1 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.3 | 0.5 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.3 | 0.3 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.3 | 2.4 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.3 | 0.8 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.3 | 2.6 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.3 | 24.3 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.3 | 1.6 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.3 | 0.8 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.3 | 1.3 | GO:0045545 | syndecan binding(GO:0045545) |
0.3 | 4.4 | GO:0031489 | myosin V binding(GO:0031489) |
0.3 | 1.8 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.3 | 7.3 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.3 | 1.0 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) glycine:sodium symporter activity(GO:0015375) |
0.3 | 1.0 | GO:0034889 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.2 | 0.7 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.2 | 2.0 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.2 | 1.0 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.2 | 0.7 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.2 | 3.9 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 0.7 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.2 | 1.5 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.2 | 1.0 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.2 | 1.7 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.2 | 2.4 | GO:0001846 | opsonin binding(GO:0001846) |
0.2 | 1.2 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.2 | 0.9 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.2 | 1.2 | GO:0030371 | translation repressor activity(GO:0030371) |
0.2 | 2.1 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.2 | 3.0 | GO:0022841 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
0.2 | 1.8 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.2 | 0.9 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.2 | 0.7 | GO:0034711 | inhibin binding(GO:0034711) |
0.2 | 1.1 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.2 | 0.5 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.2 | 0.2 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.2 | 1.1 | GO:0030957 | Tat protein binding(GO:0030957) |
0.2 | 1.6 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.2 | 0.7 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.2 | 1.3 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.2 | 3.6 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.2 | 1.3 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.2 | 1.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.2 | 0.2 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.2 | 1.3 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.2 | 0.7 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.2 | 1.7 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.2 | 0.2 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) RNA polymerase II transcription corepressor binding(GO:0001226) |
0.2 | 0.6 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.2 | 6.0 | GO:0005262 | calcium channel activity(GO:0005262) |
0.2 | 1.9 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.2 | 1.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.2 | 1.3 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.2 | 9.3 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.2 | 0.4 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.2 | 0.2 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.2 | 1.1 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.2 | 0.6 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.2 | 0.8 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.2 | 0.6 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.2 | 0.2 | GO:0050145 | uridylate kinase activity(GO:0009041) nucleoside phosphate kinase activity(GO:0050145) |
0.2 | 0.8 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 0.6 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.2 | 1.8 | GO:0070513 | death domain binding(GO:0070513) |
0.2 | 1.0 | GO:0048156 | tau protein binding(GO:0048156) |
0.2 | 3.4 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.2 | 0.4 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.2 | 4.4 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.2 | 0.8 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.2 | 0.4 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.2 | 1.6 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.2 | 0.8 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.2 | 0.8 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.2 | 0.6 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.2 | 0.6 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
0.2 | 0.2 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.2 | 1.2 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.2 | 0.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.2 | 36.6 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.2 | 0.8 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.2 | 3.0 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.2 | 1.7 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.2 | 1.3 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.2 | 1.5 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.2 | 0.6 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.2 | 0.4 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.2 | 0.7 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.2 | 0.5 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.2 | 0.4 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.2 | 1.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.2 | 0.4 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.2 | 3.4 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.2 | 0.4 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.2 | 0.4 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.2 | 0.9 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.2 | 1.0 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.2 | 0.9 | GO:0005217 | intracellular ligand-gated ion channel activity(GO:0005217) |
0.2 | 0.3 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.2 | 0.8 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 1.7 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.2 | 1.5 | GO:0038191 | neuropilin binding(GO:0038191) |
0.2 | 1.3 | GO:0031996 | thioesterase binding(GO:0031996) |
0.2 | 1.2 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.2 | 0.3 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.2 | 0.7 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.2 | 0.6 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.2 | 0.8 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 0.5 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.2 | 1.0 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.2 | 0.8 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.2 | 23.1 | GO:0008017 | microtubule binding(GO:0008017) |
0.2 | 0.3 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.2 | 0.8 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.2 | 0.5 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.2 | 0.3 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.2 | 0.5 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.2 | 0.3 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.2 | 2.3 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.2 | 0.9 | GO:0099528 | G-protein coupled acetylcholine receptor activity(GO:0016907) G-protein coupled neurotransmitter receptor activity(GO:0099528) |
0.1 | 0.4 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.1 | 0.1 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.1 | 1.9 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 1.3 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.7 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 0.4 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.1 | 3.2 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 1.4 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 0.3 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.1 | 0.4 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.1 | 7.1 | GO:0005516 | calmodulin binding(GO:0005516) |
0.1 | 0.4 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.1 | 0.8 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 1.0 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.1 | 0.4 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 1.5 | GO:0044653 | dextrin alpha-glucosidase activity(GO:0044653) starch alpha-glucosidase activity(GO:0044654) beta-glucanase activity(GO:0052736) beta-6-sulfate-N-acetylglucosaminidase activity(GO:0052769) glucan endo-1,4-beta-glucosidase activity(GO:0052859) |
0.1 | 0.4 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 1.5 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 3.5 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.1 | 0.4 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.1 | 1.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.1 | 1.6 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 0.5 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 1.7 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.4 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.1 | 2.8 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.1 | 0.5 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 0.4 | GO:1901338 | catecholamine binding(GO:1901338) |
0.1 | 1.1 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 0.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 1.4 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.4 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.1 | 0.4 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.1 | 0.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 1.1 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 3.8 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.1 | 0.7 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 0.3 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.1 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.1 | 3.2 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 1.5 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 0.7 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.1 | 0.3 | GO:0042731 | PH domain binding(GO:0042731) |
0.1 | 0.3 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.5 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.1 | 0.1 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.1 | 5.2 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 0.3 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 0.2 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.1 | 0.7 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 0.1 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.1 | 0.3 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.1 | 0.5 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 0.8 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.1 | 0.8 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 0.3 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 0.3 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.1 | 2.0 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 0.1 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 0.8 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.2 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
0.1 | 0.3 | GO:0019961 | interferon binding(GO:0019961) |
0.1 | 0.2 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 0.2 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.1 | 9.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.6 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.1 | 0.3 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 0.3 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.1 | 0.2 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.1 | 0.5 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.3 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 1.0 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.1 | 0.4 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.1 | 0.3 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.1 | 0.1 | GO:0070538 | oleic acid binding(GO:0070538) |
0.1 | 0.3 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.4 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.1 | 0.3 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 0.7 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.4 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 0.1 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.1 | 0.1 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.1 | 1.0 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.1 | 0.6 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 1.0 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.1 | 1.1 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.2 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.1 | 1.8 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.1 | 0.1 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.1 | 0.5 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 1.3 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.1 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.1 | 0.4 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.1 | 0.3 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.1 | 0.5 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 1.1 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 0.2 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 0.5 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.1 | 0.3 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.2 | GO:0032357 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.1 | 0.2 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.1 | 0.6 | GO:0005272 | sodium channel activity(GO:0005272) |
0.1 | 2.2 | GO:0019905 | syntaxin binding(GO:0019905) |
0.1 | 1.6 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.1 | 0.2 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 0.2 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.1 | 0.9 | GO:0015250 | water channel activity(GO:0015250) |
0.1 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 0.2 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.1 | 0.5 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 0.3 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.1 | 14.7 | GO:0003779 | actin binding(GO:0003779) |
0.1 | 0.3 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 0.5 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.1 | 1.3 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.8 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 1.1 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.1 | 0.8 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.1 | 3.5 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
0.1 | 1.4 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.2 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 0.2 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.1 | 0.1 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 0.1 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 0.6 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.3 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.1 | 0.3 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.2 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.1 | 5.0 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.1 | 0.1 | GO:0089720 | caspase binding(GO:0089720) |
0.1 | 0.1 | GO:0034936 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.1 | 0.1 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.1 | 0.1 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.1 | 0.2 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.1 | 2.7 | GO:0043765 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.1 | 0.2 | GO:0002054 | nucleobase binding(GO:0002054) |
0.1 | 1.0 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.2 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 0.1 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 0.1 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.1 | 0.1 | GO:0034979 | NAD-dependent histone deacetylase activity(GO:0017136) NAD-dependent protein deacetylase activity(GO:0034979) |
0.1 | 1.5 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.1 | 0.1 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.1 | 0.1 | GO:0004083 | bisphosphoglycerate 2-phosphatase activity(GO:0004083) |
0.1 | 0.4 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.1 | 1.2 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 19.7 | GO:0005509 | calcium ion binding(GO:0005509) |
0.1 | 0.4 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 0.2 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.1 | 0.2 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.1 | 0.2 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.3 | GO:0051861 | glycolipid binding(GO:0051861) |
0.1 | 0.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 0.1 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.1 | 0.3 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 0.1 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 0.8 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.3 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 0.2 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 11.4 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.1 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.0 | 0.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.7 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.1 | GO:0008808 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.0 | 0.0 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.5 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 0.1 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.0 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 1.1 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.0 | 1.2 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.0 | 0.0 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.0 | 0.3 | GO:0070402 | NADPH binding(GO:0070402) |
0.0 | 0.2 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.0 | 0.8 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.1 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.0 | 1.1 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.2 | GO:0035197 | siRNA binding(GO:0035197) |
0.0 | 0.4 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.0 | 0.5 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.2 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.0 | GO:0048030 | disaccharide binding(GO:0048030) |
0.0 | 0.1 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.0 | 11.6 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.0 | 0.3 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.3 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.4 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.4 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.0 | 0.0 | GO:0023023 | MHC protein complex binding(GO:0023023) |
0.0 | 0.1 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 1.0 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.0 | 2.3 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.0 | 0.1 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.0 | 0.8 | GO:0015631 | tubulin binding(GO:0015631) |
0.0 | 0.2 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.2 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.0 | 0.1 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.0 | 0.1 | GO:0004802 | transketolase activity(GO:0004802) |
0.0 | 0.1 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.0 | 0.1 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.0 | 0.2 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 0.0 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.0 | 0.0 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.0 | 2.2 | GO:0003729 | mRNA binding(GO:0003729) |
0.0 | 0.4 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.1 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.0 | 0.2 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.0 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.0 | 0.0 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.0 | 0.8 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.0 | 0.1 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.3 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 0.1 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.0 | 0.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.1 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.0 | 0.0 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.0 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.0 | 0.1 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.0 | 0.0 | GO:0015927 | trehalase activity(GO:0015927) |
0.0 | 0.0 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 0.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.0 | 0.0 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
0.0 | 0.0 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.0 | 0.0 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.0 | 0.1 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 0.1 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.0 | 0.0 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.0 | 0.0 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.0 | 0.1 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.0 | 0.1 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 19.9 | PID REELIN PATHWAY | Reelin signaling pathway |
0.6 | 21.4 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.6 | 11.0 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.6 | 6.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.6 | 16.9 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.5 | 8.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.5 | 21.6 | PID LKB1 PATHWAY | LKB1 signaling events |
0.5 | 15.2 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.5 | 9.3 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.5 | 10.3 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.5 | 1.0 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.4 | 1.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.4 | 3.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.4 | 0.4 | PID IGF1 PATHWAY | IGF1 pathway |
0.4 | 1.1 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.4 | 5.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.4 | 18.6 | PID NOTCH PATHWAY | Notch signaling pathway |
0.4 | 3.9 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.3 | 2.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.3 | 4.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.3 | 2.7 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.3 | 4.0 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.3 | 4.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.3 | 5.3 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.3 | 3.4 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.3 | 11.6 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.3 | 3.0 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.3 | 0.3 | ST GAQ PATHWAY | G alpha q Pathway |
0.3 | 6.4 | PID SHP2 PATHWAY | SHP2 signaling |
0.3 | 1.4 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.3 | 3.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.3 | 3.5 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.3 | 5.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.3 | 1.6 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.3 | 8.9 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.3 | 0.8 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.2 | 12.3 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.2 | 2.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 8.7 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.2 | 8.9 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.2 | 2.3 | PID ALK2 PATHWAY | ALK2 signaling events |
0.2 | 0.7 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.2 | 5.8 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.2 | 0.4 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.2 | 1.0 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.2 | 6.5 | PID AURORA B PATHWAY | Aurora B signaling |
0.2 | 2.7 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 0.8 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.2 | 0.5 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.2 | 3.1 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.2 | 2.4 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.2 | 0.2 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.2 | 1.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.2 | 0.5 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.2 | 2.5 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.2 | 2.8 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 0.2 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.2 | 3.1 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.2 | 0.3 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 1.5 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 0.9 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 1.5 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 1.2 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 1.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 0.1 | ST ADRENERGIC | Adrenergic Pathway |
0.1 | 0.9 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 1.6 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 1.2 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 0.9 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 1.4 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 0.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 1.6 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 0.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 0.9 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 1.0 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 1.1 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 0.7 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 0.5 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 0.6 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 1.0 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 1.3 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 1.1 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 0.3 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 1.4 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 0.8 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 0.9 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 0.4 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 0.3 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 0.5 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.2 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 0.6 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.3 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.5 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.0 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.3 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 0.5 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.6 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.4 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.6 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.0 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.3 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.3 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.2 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.1 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 24.7 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
1.5 | 35.3 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
1.4 | 31.2 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
1.3 | 15.7 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
1.1 | 11.0 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
1.1 | 8.6 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.9 | 10.8 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.9 | 7.1 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.9 | 8.9 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.8 | 16.0 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.8 | 8.4 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.8 | 8.3 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.7 | 5.9 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.7 | 18.5 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.7 | 6.3 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.7 | 6.9 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.7 | 4.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.6 | 5.3 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.6 | 8.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.6 | 6.7 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.5 | 10.2 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.5 | 9.3 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.5 | 12.4 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.5 | 5.9 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.5 | 0.5 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.5 | 20.2 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.5 | 2.8 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.5 | 6.6 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.5 | 5.1 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.5 | 6.0 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.4 | 6.5 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.4 | 1.2 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.4 | 0.8 | REACTOME PI3K AKT ACTIVATION | Genes involved in PI3K/AKT activation |
0.4 | 9.1 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.4 | 4.1 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.4 | 5.9 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.3 | 8.0 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.3 | 3.0 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.3 | 1.0 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.3 | 6.8 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.3 | 1.3 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.3 | 12.7 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.3 | 16.5 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.3 | 2.3 | REACTOME NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Neurotransmitter Release Cycle |
0.3 | 0.8 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.3 | 0.8 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.3 | 0.8 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.3 | 8.3 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.3 | 2.6 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.3 | 0.8 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.3 | 2.3 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.3 | 4.1 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.2 | 3.2 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.2 | 5.6 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.2 | 1.9 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.2 | 0.7 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.2 | 2.1 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.2 | 0.5 | REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX | Genes involved in Formation of RNA Pol II elongation complex |
0.2 | 2.5 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.2 | 6.1 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.2 | 1.1 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.2 | 2.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.2 | 1.5 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.2 | 2.6 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 1.0 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.2 | 2.3 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.2 | 1.8 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.2 | 1.4 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.2 | 1.4 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 2.4 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.2 | 1.5 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.2 | 6.7 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.2 | 1.7 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.2 | 3.0 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.2 | 0.7 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.2 | 1.2 | REACTOME OPIOID SIGNALLING | Genes involved in Opioid Signalling |
0.2 | 1.4 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.2 | 0.7 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.2 | 1.7 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.2 | 1.6 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.2 | 1.1 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.2 | 2.5 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 4.1 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 1.6 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 1.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 1.4 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 1.6 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 1.5 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 10.3 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 1.2 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 2.5 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 0.9 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 1.1 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 8.0 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 2.3 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
0.1 | 1.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 1.6 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 0.8 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 1.6 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 0.5 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 1.0 | REACTOME PI3K EVENTS IN ERBB4 SIGNALING | Genes involved in PI3K events in ERBB4 signaling |
0.1 | 1.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 0.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 0.2 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.1 | 1.0 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 0.8 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 0.3 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.1 | 1.4 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.1 | 1.5 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 1.6 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 0.3 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.1 | 0.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 0.9 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 1.2 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.1 | 2.2 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 1.8 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 1.1 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 1.1 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 13.4 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 0.1 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
0.1 | 0.2 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 0.9 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 0.2 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 0.8 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 0.7 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.1 | 0.1 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 0.3 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.1 | 0.6 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 1.3 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.1 | 1.1 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.1 | 1.0 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.5 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 0.9 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 0.7 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.3 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.6 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.0 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 0.1 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 0.4 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.0 | 0.2 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.0 | 0.6 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.0 | 0.2 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.8 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 5.1 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 1.2 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.2 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.3 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.4 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.6 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.3 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.0 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.0 | 0.1 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 0.1 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 0.0 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 0.8 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.1 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.0 | 0.1 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |